Printer Friendly

3SBio Inc. To Present at the DB Access Asia Conference 2012.

SHENYANG, China, May 27, 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: SSRX)("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that 3SBio will attend the DB Access Asia Conference 2012 in Singapore on May 29, 2012. A copy of 3SBio's investor presentation material for the Conference is available at www.3sbio.com/en/investors/conferences.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology nephrology

Branch of medicine dealing with kidney function and diseases. An understanding of kidney physiology is important not only in treating kidney disease but in knowing the effect of drugs, diet, and hypertension on kidney disease, and vice versa.
, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market Nasdaq stock market

The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies.
 under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor Contacts

Bo Tan Chief Financial Officer 3SBio Inc. Tel: + 86 24 2581-1820 ir@3SBio.com

Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: + 852 8191-6991 ir@3SBio.com

SOURCE 3SBio Inc.
COPYRIGHT 2012 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Article Type:Conference news
Geographic Code:9CHIN
Date:May 27, 2012
Words:265
Previous Article:DLD Introduces the Future Market of Russia.
Next Article:Rentrak Announces Worldwide Box Office Results For Weekend Of May 27, 2012.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters